
Barry Choobin
Examiner (ID: 2847)
| Most Active Art Unit | 2625 |
| Art Unit(s) | 2623, 2721, 2621, 2624, 2625 |
| Total Applications | 321 |
| Issued Applications | 267 |
| Pending Applications | 27 |
| Abandoned Applications | 27 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11075729
[patent_doc_number] => 20160272693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'AMYLIN ANALOGUES'
[patent_app_type] => utility
[patent_app_number] => 15/074526
[patent_app_country] => US
[patent_app_date] => 2016-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22734
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15074526
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/074526 | Amylin analogues | Mar 17, 2016 | Issued |
Array
(
[id] => 10977656
[patent_doc_number] => 20160174599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'BEVERAGE LOWERING SERUM CHOLESTEROL'
[patent_app_type] => utility
[patent_app_number] => 15/054803
[patent_app_country] => US
[patent_app_date] => 2016-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4949
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15054803
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/054803 | BEVERAGE LOWERING SERUM CHOLESTEROL | Feb 25, 2016 | Abandoned |
Array
(
[id] => 12043440
[patent_doc_number] => 09821025
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'Hemostatic compositions'
[patent_app_type] => utility
[patent_app_number] => 15/004520
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6987
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15004520
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/004520 | Hemostatic compositions | Jan 21, 2016 | Issued |
Array
(
[id] => 11268469
[patent_doc_number] => 20160331016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'Methods and Diets to Protect Against Chemotoxicity and Age Related Illnesses'
[patent_app_type] => utility
[patent_app_number] => 14/996946
[patent_app_country] => US
[patent_app_date] => 2016-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 21408
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14996946
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/996946 | Methods and Diets to Protect Against Chemotoxicity and Age Related Illnesses | Jan 14, 2016 | Abandoned |
Array
(
[id] => 10997405
[patent_doc_number] => 20160194352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'AMORPHOUS FORMS OF DACLATASVIR DIHYDROCHLORIDE'
[patent_app_type] => utility
[patent_app_number] => 14/988372
[patent_app_country] => US
[patent_app_date] => 2016-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4589
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14988372
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/988372 | AMORPHOUS FORMS OF DACLATASVIR DIHYDROCHLORIDE | Jan 4, 2016 | Abandoned |
Array
(
[id] => 11009773
[patent_doc_number] => 20160206726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'IMMUNOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/986046
[patent_app_country] => US
[patent_app_date] => 2015-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 31786
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14986046
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/986046 | IMMUNOTHERAPY | Dec 30, 2015 | Abandoned |
Array
(
[id] => 10743221
[patent_doc_number] => 20160089373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-31
[patent_title] => 'CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/962343
[patent_app_country] => US
[patent_app_date] => 2015-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 32627
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14962343
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/962343 | CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY | Dec 7, 2015 | Abandoned |
Array
(
[id] => 11242638
[patent_doc_number] => 09468664
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-18
[patent_title] => 'Romidepsin formulations and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/944126
[patent_app_country] => US
[patent_app_date] => 2015-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14932
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14944126
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/944126 | Romidepsin formulations and uses thereof | Nov 16, 2015 | Issued |
Array
(
[id] => 10721155
[patent_doc_number] => 20160067303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-10
[patent_title] => 'ROMIDEPSIN FORMULATIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/944115
[patent_app_country] => US
[patent_app_date] => 2015-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14700
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14944115
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/944115 | Romidepsin formulations and uses thereof | Nov 16, 2015 | Issued |
Array
(
[id] => 10784168
[patent_doc_number] => 20160130325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'METHOD FOR PRODUCING HYPO-METALLATED REDOX-ACTIVE METALLOTHIONEIN PROTEIN AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/937142
[patent_app_country] => US
[patent_app_date] => 2015-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10820
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14937142
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/937142 | METHOD FOR PRODUCING HYPO-METALLATED REDOX-ACTIVE METALLOTHIONEIN PROTEIN AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | Nov 9, 2015 | Abandoned |
Array
(
[id] => 10712672
[patent_doc_number] => 20160058819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'COMPOSITIONS OF NUTRITION SUPPLEMENTATION FOR NUTRITIONAL DEFICIENCIES AND METHOD OF USE THEREFORE'
[patent_app_type] => utility
[patent_app_number] => 14/936957
[patent_app_country] => US
[patent_app_date] => 2015-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5356
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14936957
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/936957 | Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore | Nov 9, 2015 | Issued |
Array
(
[id] => 10728369
[patent_doc_number] => 20160074518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE PI OF WHICH IS BETWEEN 5.8 AND 8.5 AND A SUBSTITUTED CO-POLYAMINO ACID'
[patent_app_type] => utility
[patent_app_number] => 14/922663
[patent_app_country] => US
[patent_app_date] => 2015-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21898
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14922663
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/922663 | Injectable solution at pH 7 comprising at least one basal insulin the pi of which is between 5.8 and 8.5 and a substituted co-polyamino acid | Oct 25, 2015 | Issued |
Array
(
[id] => 11066273
[patent_doc_number] => 20160263236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/921584
[patent_app_country] => US
[patent_app_date] => 2015-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 43745
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14921584
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/921584 | SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF | Oct 22, 2015 | Abandoned |
Array
(
[id] => 17604043
[patent_doc_number] => 11332514
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Cation and anion exchange chromatography method
[patent_app_type] => utility
[patent_app_number] => 14/920127
[patent_app_country] => US
[patent_app_date] => 2015-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6907
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14920127
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/920127 | Cation and anion exchange chromatography method | Oct 21, 2015 | Issued |
Array
(
[id] => 10978307
[patent_doc_number] => 20160175249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'Liposomes Containing Oligopeptide Fragments of Myelin Basic Protein, a Pharmaceutical Composition and a Method for Treatment of Multiple Sclerosis'
[patent_app_type] => utility
[patent_app_number] => 14/918526
[patent_app_country] => US
[patent_app_date] => 2015-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 34742
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14918526
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/918526 | Liposomes Containing Oligopeptide Fragments of Myelin Basic Protein, a Pharmaceutical Composition and a Method for Treatment of Multiple Sclerosis | Oct 19, 2015 | Abandoned |
Array
(
[id] => 13354529
[patent_doc_number] => 20180228804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => COMBINATION THERAPY OF HBV AND HDV INFECTION
[patent_app_type] => utility
[patent_app_number] => 15/514878
[patent_app_country] => US
[patent_app_date] => 2015-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15514878
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/514878 | COMBINATION THERAPY OF HBV AND HDV INFECTION | Oct 6, 2015 | Abandoned |
Array
(
[id] => 13090997
[patent_doc_number] => 10064822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-04
[patent_title] => Polypeptide based block copolymer and the process for the preparation thereof, and the polymer micelles using the same
[patent_app_type] => utility
[patent_app_number] => 14/876211
[patent_app_country] => US
[patent_app_date] => 2015-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 6833
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14876211
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/876211 | Polypeptide based block copolymer and the process for the preparation thereof, and the polymer micelles using the same | Oct 5, 2015 | Issued |
Array
(
[id] => 10665050
[patent_doc_number] => 20160011195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'Method of Forming Fragment Ligated Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/868975
[patent_app_country] => US
[patent_app_date] => 2015-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8133
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14868975
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/868975 | Method of Forming Fragment Ligated Inhibitors | Sep 28, 2015 | Abandoned |
Array
(
[id] => 12001829
[patent_doc_number] => 20170305984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'STATHERIN PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/513504
[patent_app_country] => US
[patent_app_date] => 2015-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7294
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15513504
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/513504 | STATHERIN PEPTIDES | Sep 23, 2015 | Abandoned |
Array
(
[id] => 10663620
[patent_doc_number] => 20160009764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'MU OPIOID RECEPTOR AGONIST ANALOGS OF THE ENDOMORPHINS'
[patent_app_type] => utility
[patent_app_number] => 14/845813
[patent_app_country] => US
[patent_app_date] => 2015-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12127
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14845813
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/845813 | MU OPIOID RECEPTOR AGONIST ANALOGS OF THE ENDOMORPHINS | Sep 3, 2015 | Abandoned |